White Sox prospect could miss season with ankle injury

0 Comments

Jared Mitchell.jpgBad news for one of the White Sox brightest prospects, as outfielder Jared Mitchell could miss the rest of the season with surgery for a torn ligament in his left ankle.

Mitchell injured the ankle during the sixth inning of Friday’s game against the Angels after crashing into the left field while making a spectacular catch. The 21-year-old was carted off the field and taken for X-rays.

Here’s Ozzie Guillen:

“It’s supposed to be about a year. We have to wait to see after surgery
happens. Hopefully, everything goes well. The more important thing after
that is the rehab, and hopefully, he’ll get back pretty quick. We’ll
see what happens.”

Mitchell was Chicago’s first-round pick in last year’s First-Year Player Draft. The LSU product batted .296/.417/.435 with zero homers, 10 RBI and five stolen bases in 115 at-bats for Single-A Kannapolis in his pro debut last season, but has drawn raves from scouts about his power-speed potential. He was recently ranked as the organization’s No. 1 prospect by Baseball America. Let’s hope it’s not a complete lost season for the youngster.
 

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.